I guess that I knew this was coming eventually, but it still took me by surprise to see it in the news.
A pharmaceutical company has signed a licensing agreement to produce human lactoferrin, a component of breastmilk (and other human secretions) which is known to have multiple important functions in the immunological defense of infants.
Biotech company
Pharming
Group NV and
Aslan Group A.S. from Istanbul, Turkey today
announced that
they have signed a full licensing agreement to
further develop,
manufacture and market Pharming's human lactoferrin
product (hLF).
Earlier in 2008, the companies concluded a
commercialization and
supply agreement for the marketing and
distribution of food or food
supplements containing Pharming's hLF.
Aslan will produce a herd of transgenic cows with the ability to express human lactoferrin in their milk. They will also build one or more farms and facilities for housing the herd which will be produced by expanding the experimental herds already generated by Pharming. Milk fractions containing human lactoferrin will be incorporated into nutritional products to be marketed to people who will benefit from the use of lactoferrin.
Want to get email updates from the Motherwear Breastfeeding Blog? Subscribe here. Want an RSS feed? Click here.
